Lupin gains FDA approval for generic Toprol-XL Tablets
Lupin Limited, a dominant player in the global pharmaceutical landscape, announced its triumph in obtaining the coveted approval from the United States Food and Drug Administration (FDA). This authorization is for Lupin’s Abbreviated New Drug Application (ANDA) for Metoprolol Succinate Extended-Release Tablets USP in the concentrations of 25 mg, 50 mg, 100 mg, and 200 […]